 Hence, the case was properly removed to federal court.In "Association for Accessible Medicines v. Frosh",  Lefkowitz secured a major victory on behalf of his client in the United States Court of Appeals for the Fourth Circuit.During its 2017 legislative session, the State of Maryland had passed a law prohibiting a manufacturer or wholesale distributor from “engag[ing] in price gouging in the sale of an essential off-patent or generic drug.” Md.